Rigel Pharmaceuticals Cash Flow

Health Care & Life Sciences » Pharmaceuticals | Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.

2013

2014

2015

2016

2017

2018

Net Income before Extraordinaries

89,027.00

90,908.00

51,464.00

69,216.00

77,992.00

70,480

Depreciation, Depletion & Amortization

2,592.00

2,359.00

1,439.00

941.00

465.00

594

Other Funds

6,709.00

18,991.00

7,346.00

8,178.00

5,400.00

6,938

Funds from Operations

79,726.00

69,558.00

42,679.00

60,097.00

72,127.00

62,948

Changes in Working Capital

6,335.00

195.00

19,266.00

15,792.00

5,430.00

4,122

Net Operating Cash Flow

86,061.00

69,753.00

23,413.00

75,889.00

77,557.00

58,826

Capital Expenditures

1,221.00

413.00

546.00

804.00

164.00

Sale of Fixed Assets & Businesses

234.00

60.00

88.00

732.00

Purchase/Sale of Investments

73,601.00

63,111.00

45,099.00

25,597.00

20,041.00

Net Investing Cash Flow

72,380.00

62,932.00

44,613.00

24,881.00

19,473.00

Net Financing Cash Flow

1,051.00

1,170.00

7,053.00

25,184.00

117,688.00

Net Change in Cash

12,630.00

5,651.00

28,253.00

25,824.00

20,658.00

Free Cash Flow

87,282.00

70,166.00

23,959.00

76,693.00

77,721.00

Change in Capital Stock